Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B. Clinics, [S. l.], v. 68, n. 10, p. 1325–1332, 2013. DOI: 10.1590/clin.v68i10.77009. Disponível em: https://www.revistas.usp.br/clinics/article/view/77009.. Acesso em: 20 may. 2024.